ReviewArchives of Razi Institute2025
Glauconite: A Natural Ally in Cancer Prevention and Treatment.
Review in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glauconite: A Natural Ally in Cancer Prevention and Treatment.Archives of Razi Institute · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glauconites, a group of clay minerals, have received attention for their potential anti-cancer properties. These properties are attributed to their antioxidant, apoptotic, and anti-angiogenic activities. Glauconites contain antioxidants, such as flavonoids and tannins, which neutralize free radicals. Glauconites are composed of a rich blend of minerals, including iron oxide, aluminium oxide, and potassium oxide. These elementsare arranged in a layered structurethat provide a multifaceted defense against radiation. Glauconite extracts induce apoptosis, or programmed cell death mechanism, in cancer cells, thereby halting their growth and spread. As research on glauconite progresses, it is evident that this naturally occurring mineral has great potential as a radiation shield. With further development and refinement, glauconite could potentially play a crucial role in protecting individuals and environments from the harmful effects of radiation, and safeguarding human health and well-being. Moreover, glauconite inhibits angiogenesis, the formation of new blood vessels, which deprives cancer cells of their nutrient supply and hinders their proliferation. Animal studies have provided promising evidence supporting glauconite's anti-cancer properties. Studies in animal models have shown that treatment with glauconite extracts significantly reduces both tumour size and cancer cell proliferation. Further research is imperative to fully elucidate the mechanisms and therapeutic potential of glauconite in cancer treatment.Glauconite has vast potential as a radiation shield. It could be incorporated into protective clothing and materials used in workplaces with radiation exposure, such as nuclear power plants and medical facilities. Additionally, glauconites could be used to purify waterand soil contaminated by radioactivity, thereby protecting public health and the environment. Further research is necessary to fully elucidate the mechanisms and therapeutic potential of glauconite in cancer treatment. Glauconite holds promise as a novel and effective approach to cancer therapy, warranting further investigation for potential clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.